glp-1 obesity drug news today 2025-10-20 A second helping of weight-loss drugs is coming 2024 was a record year
Description
These advanced therapies often carry premium pricing, contributing to market growth even as generics and biosimilars enter the market
The search strategy employed a combination of Medical Subject Headings (MeSH) terms and free-text keywords including: glucagon-like peptide-1 receptor agonist, GLP-1, semaglutide, liraglutide, dulaglutide, tirzepatide, perioperative, preoperative, anaesthesia, anesthesia, gastric emptying, aspiration, regurgitation, delayed gastric emptying, and pulmonary aspiration
Roth, J
Watanabe, J
They include: Semaglutide ( Wegovy ): A GLP-1 agonist, which triggers hormonal activity to keep blood sugar low, reduce cravings, and increase feelings of fullness
Clinicians working in eating disorder settings have begun documenting this pattern
